Apellis Pharmaceuticals (APLS)
(Delayed Data from NSDQ)
$36.00 USD
-3.60 (-9.09%)
Updated Aug 1, 2024 04:00 PM ET
After-Market: $36.00 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *BMO8/1/24 |
---|---|
Current Quarter | -0.33 |
EPS Last Quarter | -0.54 |
Last EPS Surprise | 0.00% |
ABR | 1.53 |
Earnings ESP
|
23.06% |
---|---|
Current Year | -1.14 |
Next Year | 0.61 |
EPS (TTM) | -3.46 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 189.47M | 211.74M | 803.59M | 1.10B |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 207.17M | 238.17M | 887.19M | 1.32B |
Low Estimate | 180.27M | 199.04M | 774.69M | 952.10M |
Year ago Sales | 94.97M | 110.40M | 396.59M | 803.59M |
Year over Year Growth Est. | 99.50% | 91.79% | 102.62% | 36.69% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.33 | -0.20 | -1.14 | 0.61 |
# of Estimates | 11 | 9 | 11 | 11 |
Most Recent Consensus | -0.09 | 0.11 | -0.13 | 2.33 |
High Estimate | -0.09 | 0.11 | -0.13 | 2.33 |
Low Estimate | -0.42 | -0.32 | -1.50 | -0.88 |
Year ago EPS | -1.02 | -1.17 | -4.45 | -1.14 |
Year over Year Growth Est. | 67.65% | 82.91% | 74.38% | 153.59% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 3 | 2 | 3 | 1 |
Down Last 7 Days | 1 | 1 | 1 | 1 |
Down Last 30 Days | 2 | 2 | 2 | 4 |
Down Last 60 Days | 2 | 2 | 2 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.20 | -0.10 | -1.14 | 0.61 |
7 Days Ago | -0.20 | -0.09 | -1.12 | 0.62 |
30 Days Ago | -0.19 | -0.07 | -1.08 | 0.69 |
60 Days Ago | -0.21 | -0.09 | -1.15 | 0.86 |
90 Days Ago | -0.25 | -0.09 | -1.27 | 1.09 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.25 | -0.12 | -0.84 | 0.80 |
Zacks Consensus Estimate | -0.33 | -0.20 | -1.14 | 0.61 |
Earnings ESP | 23.06% | 41.30% | 25.92% | 30.37% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.28 | -0.54 | -0.73 | -1.17 | NA |
Estimate | -0.33 | -0.54 | -0.66 | -0.84 | NA |
Difference | 0.05 | 0.00 | -0.07 | -0.33 | -0.09 |
Surprise | 15.15% | 0.00% | -10.61% | -39.29% | -8.69% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more